Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies

April 26, 2026
, 5:46 pm

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

The World Health Organization has prequalified Coartem Baby, the first and only antimalarial for babies. Novartis developed this combination drug in partnership with Medicines for Malaria Venture.

The post Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies appeared first on MedCity News.

Leave a Replay

What Dentistry Is Teaching Healthcare About Operational AI

Patients are Turning to HCP Influencers in the Age of AI and Misinformation

Too Many Prescriptions, Too Many Fatal Falls

Sign up for our Newsletter

HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.

Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies

Leave a Replay

Related Posts

What Dentistry Is Teaching Healthcare About Operational AI

Patients are Turning to HCP Influencers in the Age of AI and Misinformation

Too Many Prescriptions, Too Many Fatal Falls

Follow Us

Sign up for our Newsletter

Our Company

Resources

Connect

© All rights reserved

Contact Us